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1. Introduction  
One of the goals in long-term cares for patients with diabetes mellitus (DM) is to prevent 
the development of micro-and macro- vascular complications (The International Diabetes 
Federation, 2011). To achieve this purpose, an adequate control of blood pressure (BP) as 
well as a good glycaemic control is crucial (The International Diabetes Federation, 2011). 
The American Diabetes Association recommended that the BP goal should be lowered to 
130/80 mmHg in the daytime of clinic setting (The American Diabetes Association, 2002-
2011).  
However, in 4733 patients with type 2 DM at high risk for cardiovascular events followed 
the mean of 4.7 years, targeting a systolic casual/clinic BP (CBP) in the daytime of less 
than 120 mmHg as compared with less than 140 mmHg, did not reduce the rate of a 
composite outcome of fatal and nonfatal major cardiovascular events (ACCORD Study 
Group, 2010). Further, in 16,893 patient-years of follow-up at 862 sites in 14 countries, a 
tight control of systolic CBP in the daytime among patients with DM and cardiovascular 
disease to achieve systolic CBP in the daytime of less than 130 mmHg and diastolic CBP of 
less than 85 mmHg was not associated with improved cardiovascular outcomes compared 
with usual control (Cooper-DeHoff et al, 2010). At present, the reasons of difference are 
not clear. 
Recently, a discrepancy between screening BP by CBP measurment and ambulatory BP by 
ambulatory blood pressure monitaring (ABPM) has been noted. It has also been shown that 
in patients with essential hypertension, home BP (HBP) measurement in the morning has a 
stronger predictive power for mortality than CBP measurements in the daytime (Aihara et 
al, 1998, Ohkubo et al, 1998, Imai et al, 1999). Accordingly, the difference of results 
(ACCORD Study Group, 2010, Cooper-DeHoff et al, 2010) may be due to be not evaluated 
BP in the midnight or in the morning by ABPM or HBP measurements.      
To evaluate the usefulness of HBP measurement in the morning in patients with DM, we 
examined whether BP elevations at the awakening-up in the morning detected by HBP were 
more predictive than those in the daytime detected by CBP for micro- and macro- vascular 
complications in patients with type 1 or 2 DM, as observed in patients with essential 
hypertension (Aihara et al, 1998, Ohkubo et al, 1998, Imai et al, 1999). 
Our cross-sectional studies have demonstrated that HBP measurements at the awakning-up 
in the morning offer stronger predictive power for micro- and macro-vascular complications 
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in patients with type 1 and 2 DM than CBP measurements in the daytime (Kamoi et al, 2002-
2003). Further, a study examined which of HBP at the awakning-up in the morning or CBP 
in the daytime provides the stronger predictive power for outcomes by comparing 
cumulative events between hypertensive and normotensive patients over 6 years in a 
prospective and longitudinal study of patients with type 2 DM (Kamoi et al, 2010). 
2. Research design and methods 
2.1 Subjects 
2.1.1 A cross-sectional study 
In a cross-sectional study, 10 years ago we studied on 53 Japanese patients with type 1 DM 
who visited our clinics regularly (Kamoi et al, 2003). The diagnosis of type 1 DM was based 
on the World Health Organization (WHO) criteria (AlbertiK et al, 1998). Numbers of female 
patients were twice of male patients. The age was 23 to 81 year old and the duration was 2 to 
47 years (Table 1). Of 53 patients, 38 (72%) were treated by multiple daily insulin injections 
and remaining (28%) by subcutaneous continuous insulin infusion therapy for DM. Twenty 
two patients (42%) were treated with anti-hypertensive drugs at the beginning of the study 
(Table 2). Also, we studied on 170 Japanese patients with type 2 DM. They visited our clinic 
regularly (Kamoi et al, 2002). The diagnosis of type 2 DM was based on the WHO criteria 
(AlbertiK et al, 1998). The clinical characteriscs are shown in the Table 3. Ratio of numbers in 
female and male patients was similar. The mean age was middle and the mean BMI was 
within normal range (Table 3). Of 170 patients, 153 (90%) were treated with oral 
hypoglycaemic drugs and/or insulin regimens for DM, whereas 80 (47%) were treated with 
anti-hypertensive drugs at the beginning of the study (Table 4). 
2.1.2 A longitudinal study 
In a longitudinal study, subjects comprised 400 Japanese patients with type 2 DM enrolled 
between 1999 and 2005 including the patients participated in the cross-sectional study 
(Kamoi et al, 2010). After a detailed baseline examination (Table 5), subjects were followed 
up for all-cause mortality and morbidity.  
All participants visited our clinic regularly and were observed until February 28, 2007. 
Mean survey duration of all patients was 42 ± 20 months (range, 3–72 months). Type 2 
DM was diagnosed according to WHO criteria (AlbertiK et al, 1998). No significant 
difference in the number of patients was noted between females and males. Mean subjects 
were also middle ages. The mean BMI was within normal range (Table 5). At the 
beginning of the study, 329 patients (82%) were receiving treatment with oral 
hypoglycaemic drugs and/or insulin regimens for DM and 196 patients (49%) were 
receiving treatment with various anti-hypertensive drugs (angiotensin-converting enzyme 
inhibitors, angiotensin receptor blockers, calcium channel blocker, and others) for 
hypertension (Table 6). For ethical reasons, patients were treated with various anti-
hypertensive, anti-diabetic, anti-dyslipidemia, and/or anti-hypercoagulation agents 
during the course of the study by the patients’ own doctors as a part of a continuing 
standard of medical care. 
All patients were fully informed about the purposes and the procedures for study and 
provided oral consent at enrolment. 
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Data are means 士 SD. The systolic BP (SBP) and the diastolic BP (DBP) levels in all patients were 
measured at the clinic in the daytime and at the home at the awakening-up in the morning, 
resepectively. CH; clinic hypertension, CN; clinic normotension, MH; morning hypertension, MN; 
morning normotension, Cr; creatinine, UERA; urinary excretion rate of albumin. **P<0.01 versus 
patients with CN;‡P<0.01 versus patients with MN; and †P<0.01 versus patients measured at the clinic in 
the daytime. 
Table 1. Characteristics of patients with type 1 diabetes mellitus in a cross-sectional study 
2.2 Method 
2.2.1 Blood pressure 
2.2.1.1 CBP 
CBP levels were measured once in clinical setting of a daytime during each clinic visit. HBP 
was also measured once each morning, in the sitting position within 10 min after 
awakening, for every day. For the CBP levels in the daytime, when patients with DM had 
clinic systolic BP 130 mmHg and/or clinic diastolic BP 85 mmHg, we classified these 
patients as having clinic hypertension (CH) by the criteria of the WHO and International 
Society of Hypertension guide lines (Guide lines Subcommittee, 1999).  
    107+112

       6.9+3.7       42+79         324+567

      7.1+6.9         7.8+287      66+240 
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Data are number. Odds ratio for CH and CN groups was calculated. MDI; multiple daily insulin 
injections, CSII; subcutaneous continuous insulin infusion, CI; confidence interval.  
Table 2. Prevalence of micro- and macro- vascular events and medical treatment in patients 
shown in the table 1 
2.2.1.2 HBP 
When the HBP levels at the awakening-up in the morning were systolic HBP 130 mmHg 
and/or diastolic HBP 85 mmHg, we classified these patients as having morning 
hypertension (MH). When these values were 130 mmHg of systolic BP and 85 mmHg of 
diastolic BP, we classified these patients as having clinic normotension (CN) or morning 
normotension (MN), respectively. 
All subjects were divided into two groups: with CH or MH and without CH or MH. Finally, 
we examined whether CBP in the daytime and HBP at the awakening-up in the morning is 
more predictive of these events.   
2.2.2 Micro- and macro- vascular complications 
The microvascular complications detected in this study were nephropathy and retinopathy. 
Occurrence of nephropathy was evaluated each three months in the clinic setting from 
beginning of the study based on urinary excretion rate of albumin (UERA), whereas 
occurrence of retinopathy was evaluated at least once each 6 months during the study. The 
macrovascular complications defined were coronary heart disease (CHD) and 
cerebrovascular disease (CVD) assessed by clinical situation. Prevalence of these events was 
confirmed by medical history at the beginning of the study.  
www.intechopen.com
 
Prevention for Micro- and Macro-Vascular Complications in Diabetic Patients 
 
341 
 
Data are means 士 SD. The systolic BP (SBP) and the diastolic BP (DBP) levels in all patients were 
measured at the clinic in the daytime and at the home at the awakening-up in the morning, resepectively. 
CH; clinic hypertension, CN; clinic normotension, MH; morning hypertension, MN; morning 
normotension, Cr; creatinine, UERA; urinary excretion rate of albumin. **P<0.01 versus patients with CN 
;‡P<0.01 versus patients with MN ; and †P<0.01 versus patients measured at the clinic in the daytime.  
Table 3. Characteristics of patients with type 2 diabetes mellitus in a cross-sectional study 
2.2.3 Glycaemic control and other variables 
Glycaemic control was evaluated by HbA1c values (JDS: normal range 4.5–5.7%) (Kasezawa 
et al, 1987). Other variables, including serum concentrations of electrolytes and lipids, were 
also measured (Kamoi et al, 2002). Albumin concentration in random spot urine was 
measured by the latex agglutinination photometric immunoassay method (Kamoi et al, 
2002).    
2.2.4 Analytical methods 
2.2.4.1 CBP  
CBP level was measured by patient’s self at the clinic in the daytime in the left arm after a 5-
min rest in a sitting position using an automatic device based on the cuff-oscillometric 
method (FT-200; Parama-Tech, Fukuoka, Japan).  
   212+524τ    11+8*      125+405*      1,113+2,449τ   7.5+5.0    660+1,943   248+1,013 
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Data are %. The prevalence is a percent ratio of patient with MH, MN, CH, CN, or all patients. Odds 
ratio for CH and CN groups was calculated. *P<0.01 versus patients with CN, †P<0.01 versus patients 
with MN. CI: confidence interval.  
Table 4. Prevalence of micro- and macro- vascular events and medical treatment in patients 
shown in the table 3  
2.2.4.2 HBP  
HBP level was measured at the home in the morning within 10 min after awakening, by a 
patient’s self or a family member, in the left arm in a sitting position. Semiautomatic devices 
based on the cuff-oscillometric principles that generate a digital display of both systolic BP 
and diastolic BP were used. All devices met the criteria set by the Association for the 
Advancement of Medical Instrumentation. A standard arm cuff was used to measure both 
CBP and HBP levels. 
2.2.4.3 Variable parameters 
Venous samples were collected during each clinic visit and were analysed for HbA1c levels 
and concentrations of total cholesterol (TC), low densty lipoprotein cholesterol (LDL), high 
densty lipoprotein chesterol (HDL), triglyceride (TG), and creatinine without fasting. 
Microalbuminuria and clinical albuminuria were defined as UERA 30 and 300μg/mg 
creatinine, respectively (The American Diabetes Association, 2002).  
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Data represent mean ± SD. Morning and clinic blood pressures were measured at the home at the 
wakening-up in the morning and at the clinic in the daytime, respectively. CH; clinic hypertension, CN; 
clinic normotension, MH; morning hypertension, MN; morning normotension, Cr; creatinine, UERA; 
urinary excretion rate of albumin. For comparisons of UERA, unpaired t test with Welch's correction 
was used. †P<0.05 versus patients with normotension; **P<0.01 versus patients measured at the clinic in 
the daytime.  
Table 5. Baseline characteristics of patients with type 2 diabetes mellitus on the basis of HBP 
measurement in a longitudinal study 
    206+646τ             26+113                   141+369              187+854 
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Data represent means ± SD. Morning and clinic blood pressures were measured at the home at the 
awkening-up in the morning and in the clinic in the daytime, respectively. *Numbers in parentheses 
represent a percentage ratio of patients in each type for all subjects. CI: confidence interval. †P<0.05 
versus patients with normotension; **P<0.01 versus patients measured at the clinic. 
Table 6. Prevalence of micro- and macro- vascular events and medical treatment in patients 
shown in the table 5 
2.3 Statistical analysis  
2.3.1 Baseline 
All values are presented as means 土 SD. Mean values were compared using chi square test or 
un-paired Student’s t test. To compare the prevalence of micro- and macro-vascular 
complications in groups with and without the hypertension, Yates ‘continuity corrected x2 test 
with two-tailed P value was performed and odds ratios were calculated; if prevalence of the 
events was 0.5 was added to all values before calculating the odds ratio and 95% CIs were 
provided. Multiple logistic analyses were used to determine the contribution of the variables 
to the events. Correlation between HBP and CBP levels was calculated. In addition, receiver 
operating characteristic (ROC) curves for HBP and CBP with various end points were used to 
examine whether HBP levels in the morning and CBP levels in the daytime behave differently 
in allowing ascertainment of the true risk or whether the 130/85 mmHg cut points are better 
for HBP levels in the morning than for CBP levels in the daytime.  
www.intechopen.com
 
Prevention for Micro- and Macro-Vascular Complications in Diabetic Patients 
 
345 
 
Table 7. Multivariate-adjusted odds ratios and 95%CIs of risk factors for nephropathy in 
patients with type 1 diabetes 
2.3.2 Endpoints and outcome measures 
Differences in outcomes for each endpoint of death, and new or worsened micro- and 
macro- vascular complications between hypertensive and normotensive patients on the 
basis of HBP levels in the morning or CBP levels in the daytime were assessed using 
survival curves calculated according to Kaplan-Meier methods, then compared by a hazard 
ratio using the log-rank test. Within the survey time previously defined, a time until 
censoring or death (or occurrence of the event) was calculated for each endpoint. 
2.3.3 Risk factor assessment for outcomes 
In a longitudinal study, risk factors related to outcomes determined statistically by a log-
rank test were assessed using hazard ratios by Cox proportional hazards model. For 
outcomes of microvascular complications, risk factors were determined in new, worsened, 
or improved events. Omnibus tests were used to determine the appropriateness of Cox 
proportional hazards modelling. Confounding factors used in this analysis were variables 
with MH in the morning or CH in the daytime at baseline and additional therapy for each 
disease. The analysis was based on the first event of each participant, thereby, allowing each 
participant to enter once in the Cox proportional hazard models. 
These analyses were performed using the GraphPad Prisms of software (version 3.02-5.01; 
GraphPad Soft-ware, San Diego, CA, USA), the Statistical Package for the Biosciences (SPBS; 
Anti-hypertensive drugs
Anti-diabetic drugs
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Winesteem Institute of Community Medicine, Tokyo, Japan) and the Dr. SPSSII for 
Windows (SPSS Japan, Tokyo, Japan). A two-tailed value of P< 0.05 was considered 
statistically significant. 
 
 
Table 8. Multivariate-adjusted odds ratios and 95%CIs of risk factors for nephropathy in 
patients with type 2 diabetes  
3. Results 
3.1 In a cross-sectional study 
3.1.1 A type 1 diabetes mellitus 
As shown in the figure 1, in type 1 diabetic groups with both CH and CN, the kinds of anti-
hypertensive medicines administered after taking breakfast in the groups with MH were 
greater than in the groups with MN. There were no significant differences in the prevalence 
of nephropathy and retinopathy between the two groups with CH and CN. In contrast, the 
prevalence of nephropathy with 8 microalbuminuria and 3 clinical albuminuria in the patients 
with MH was significantly higher than those with MN (Table 2). The prevalence of 
proliferative retinopathy in the patients with MH was significantly higher than that in those 
with MN, although there was no significant difference in all types of retinopathy between two 
groups. There was no occurrence of CHD or CVD in the two groups. Specifically, systolic MH 
made a significant (r = 0.66, P = 0.001) contribution to the occurrence of nephropathy by 
multiple regression analysis, whereas the difference is not related to age, sex, duration of 
diabetes, BMI, HbA1c, and serum lipid concentrations or use of different methods of insulin 
therapy and anti-hypertensive drugs. Meanwhile, the duration of diabetes had a significant (r 
= 0.4, P = 0.001) contribution to the occurrence of retinopathy (Table 7). No relationships 
Anti-hypertensive drugs
Anti-diabetic drugs
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between systolic HBP and diastolic HBP, and systolic CBP and diastolic CBP measurements 
were observed (morning systolic HBP = 0.28, systolic CBP = 0.07, P = 0.06 and diastolic HBP = 
0.25, diastolic CBP = 0.14, P = 0.005). The area under the ROC curve (AUC) of morning systolic 
HBP (0.99 ± 0.01) was significantly higher (P < 0.001) than that of systolic CBP (0.49 ± 0.10) in 
nephropathy (Figure 2). There was no statistical difference in AUC between them in other 
events. In nephropathy, sensitivities of 130 mmHg threshold in morning and clinic systolic BP 
were 1.0 (95% CI 1.0–1.0) and 0.55 (0.23–0.83), respectively, whereas those of 85 mmHg 
threshold in morning and clinic diastolic BP were 0.64 (0.31-0.89) and 0.55 (0.23–0.83), 
respectively. Specificities of 130 mmHg threshold in morning and clinic systolic BP were 0.95 
(0.84–0.99) and 0.48 (0.32–0.64) (Figure 3), respectively, whereas those of 85 mmHg threshold 
in morning and clinic diastolic BP were 0.14 (0.05–0.29) and 0.29 (0.16–0.45), respectively.  
 
 
Fig. 1. Various kinds of anti-hypertensive medicines in each group with CH or CN and MH 
or MN in patients with type 1 diabetes mellitus in a cross-sectional study. These anti-
hypertensive medicines were administered after taking a breakfast. CH; clinic hypertension, 
CN; clinic normotension,MH; morning hypertension, MN; morning normotension, ARB; 
angiotensinⅡreceptor blocker, CCB; calcium channel blocker , ACE inhibitor; angiotensin 
converting enzyme inhibitor. 
3.1.2 A type 2 diabetes mellitus 
As shown in the figure 4, in the type 2 diabetic groups with both CH and CN, the kinds of 
anti-hypertensive medicines administered after taking breakfast in the groups with MH 
were also greater than in the groups with MN as those in patients with type 1 diabetes 
(Table 4). Comparing the characteristics of patients with and without CH, the following 
trends were noted. The prevalence of CH was four times higher than CN. BMI in CH 
patients was slightly higher than in CN patients. In contrast, serum creatinine concentration 
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and UERA in CH patients were significantly lower than in CN patients (Table 3). No 
significant differences in other variables were noted between the two groups (Tabel 4). A 
total of 48% of CH patients were being treated with anti- hypertensive drugs, compared 
with 44% of CN patients (Tabel 4).   
 
 
 
Fig. 2. ROC analysis in nephropathy in patients with type 1 and 2 diabetes mellitus. 
 
 
 
 
Fig. 3. Threshold of systolic HBP at the wakening-up for prevalence of micro- and macro-
vascular events in patients with type 1 and 2 diabetes mellitus. The vertical arrow indicated 
the value of threshold of systolic HBP. 
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Fig. 4. Various kinds of anti-hypertensive medicines in each group with CH or CN and MH 
or MN in patients with type 2 diabetes mellitus in a cross-sectional study. CH; clinic 
hypertension, CN; clinic normotension, MH; morning hypertension, MN; morning 
normotension, ARB; angiotensin Ⅱreceptor blocker, CCB; calcium channel blocker , ACE 
inhibitor; angiotensin converting enzyme inhibitor 
When we compared the prevalence of diabetic complications in the two groups, there were 
no significant differences in the prevalence of nephropathy, retinopathy, CHD, and CVD 
between the two groups. However, the prevalence of clinical albuminuria in CH patients 
was lower than in CN patients (Table 2).  
The CH patients were further divided into two groups: with and without MH (Table 3). BMI 
in MH patients was slightly higher than in MN patients. Systolic BP, diastolic BP, and UAER 
in MH patients were significantly higher than those in MN patients. There were no 
significant differences in other variables between the two groups. Nephropathy was 
observed in 69% of MH patients, whereas there was no nephropathy in MN patients. The 
prevalences of retinopathy and CVD in MH patients were also significantly higher than in 
MN patients (Table 4). The prevalence of treatment with anti- hypertensive drugs was 
higher in MH than in MN (Table 4).  
The CN patients were also divided into two groups: with and without MH (Table 3). The 
means of age, BMI, systolic HBP, and diastolic HBP in MH patients were significantly 
higher than those in MN patients. Serum creatinine concentration and UAER were also 
higher in MH than in MN. No significant differences in other variables were shown between 
the two groups. However, the prevalence of nephropathy in MH patients was high (91%), 
whereas no nephropathy was observed in MN patients. The prevalences of retinopathy, 
CHD, and CVD in MH patients were also higher than in MN patients. More MH patients 
than MN patients were being treated with anti- hypertensive drugs (Table 4).  
Comparing the characteristics of the two patient groups with and without MH, the 
following trends were noted (Table 3). The means of age, sex, HbA1c levels, and lipid 
concentrations were not different between the two groups. However, systolic BP and 
diastolic BP, based on HBP in the morning, in MH patients were significantly higher than in 
MN patients. Serum creatinine concentration and UAER were also higher in MH patients 
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(Table 3). The prevalences of treatment with anti-hypertensive and anti-diabetic drugs were 
3 and 1.5 times higher, respectively, in MH patients compared with MN patients (Table 4). 
The prevalence of nephropathy in MH patients was 75%, whereas no nephropathy was 
noted in MN patients. The prevalence of retinopathy in MH patients was twice that found in 
MN patients, although there was no difference in the prevalences of non-proliferative and 
proliferative retinopathies between the two groups (Table 4). The prevalences of CHD and 
CVD in MH patients were four and six times higher, respectively, than in MN patients.  
Specifically, the prevalence of nephropathy in all subjects was highly associated (P < 0.001) 
with systolic MH, but not with age, sex, HbA1c, serum lipid concentrations without LDL, and 
use of anti-diabetic drugs by multiple logistic analysis. However, prevalence of nephropathy 
was associated with BMI, LDL concentration, serum creatinine concentration, and use of anti- 
hypertensive drugs and was negatively associated with diastolic CBP (Table 8).  
The relationships between systolic HBP and diastolic HBP in morning and clinic 
measurements were described by regression equations of morning systolic HBP = 0.23 
systolic CBP + 111 and morning diastolic HBP = 0.26 diastolic CBP + 58, respectively. The 
correlations were poor (morning versus clinic systolic BP, r = 0.05, P = 0.004; morning versus 
clinic diastolic BP, r = 0.09, P = 0.0001). In comparison of ROC curves for HBP and CBP with 
the events, the areas under ROC curves of morning systolic HBP (0.86 ± 0.39) and morning 
diastolic HBP (0.70 ± 0.52) were significantly higher (P < 0.001 and P = 0.035, respectively) 
than those of systolic CBP (0.52 ± 0.60) and diastolic CBP (0.57 ± 0.59) in nephropathy, 
indicating that HBP has a higher predictive value than CBP (Figure 2). In contrast, there 
were no statistical differences between them in other events. In nephropathy (Figure 2), 
sensitivities of the 130 mmHg threshold in morning and clinic systolic BP were 1.00 (1.00–
1.00 95% CI) and 0.18 (0.10–0.29), respectively, whereas those of the 85 mmHg threshold in 
morning and clinic diastolic BP were 0.49 (0.37–0.61) and 0.43 (0.31–0.55), respectively. 
Specificities of the 130 mmHg threshold in morning and clinic systolic BP were 0.68 (0.58–
0.77) and 0.85 (0.76–0.91) (Figure 3), respectively, whereas those of the 85 mmHg threshold 
in morning and clinic diastolic BP were 0.75 (0.65–0.83) and 0.73 (0.64–0.82), respectively. 
3.2 In a longitudinal study 
3.2.1 Baseline characteristics of patients  
In the patients with a type 2 DM, baseline characteristics of patients classified as hypertensive 
or normotensive on the basis of HBP and CBP are shown in Tables 5, respectively. Based on 
HBP, prevalence of MH was double that of MN. Mean age, duration of disease, BMI, systolic 
BP and diastolic BP in both HBP and CBP, serum creatinine concentration and UAER were 
also significantly higher with MH than with MN (Table 5). In MH patients, morning diastolic 
HBP was significantly lower than diastolic CBP. In MN patients, morning systolic and diastolic 
HBP were significantly lower than systolic and diastolic CBP, respectively. No significant 
differences were noted in other laboratory variables between the two groups. Prevalence of 
microvascular complications was significantly great higher with MH than with MN, and 
prevalence of nephropathy was about 9-fold higher with MH than with MN (Table 6), 
although there was no dialysis. Prevalence of macrovascular complications was also 
significantly higher with MH than with MN. Most patients showing MH received anti-
hypertensive and anti-diabetic drugs. The prevalence of patients receiving anti-hypertensive 
drugs was 6-fold higher for MH than for MN. The prevalence of patients receiving anti-
diabetic drugs appeared 1.5-fold higher with MH than with MN, although no significant 
difference was evident. Prevalences of using anti-dyslipidemia and anti-hypercoagulation 
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agents were also significantly higher with MH than with MN (Table 6), but prevalences were 
lower than those for anti-hypertensive and anti-diabetic drugs.   
On the basis of CBP, most characteristics of CH and CN patients at baseline were similar to 
those of MH and MN patients, respectively (Table 5). However, no significant differences in 
mean age, duration of disease, serum creatinine concentration or UAER or in prevalences of 
retinopathy and macrovascular complications were noted between these patients. 
Meanwhile, mean LDL was significantly lower with CH than with CN. In patients with CN, 
morning systolic and diastolic HBP were significantly higher than systolic and diastolic 
CBP, respectively (Table 5). 
3.2.2 Endpoints and outcome measures 
Nine cumulative events (2.3%) of death were observed for 6 years (Figure 6). They were 
with sustained MH, whereas none occurred in patients with sustained MN (Table 9). The 
hazard ratio was significantly (5-fold) higher with sustained MH than with sustained MN.  
 
 
Table 9. Primary and secondary outcomes in a longitudinal study. 
On the causes of death, 3, 3, 2 and 1 patients in the MH group were due to cancer with brain, 
breast or pancreas, CVD, CHD and unknown cause, respectively. while 3, 1, 1 and 1 patients 
in the CH group were due to cancer with brain, breast or pancreas, CVD, CHD and 
unknown cause, respectively, and 2 and 1 patients in the CN group were due to CVD and 
CHD, respectively (Kamoi et al, 2010). As shown in figure 7, new or worsened events of 
microvascular complications were observed in 72 patients (18%) included 36 with 
retinopathy and 59 with nephropathy, while improved events of microvascular 
complications were shown in 102 patients (25.5%) included 27 with retinopathy and 79 with 
nephropathy. New or worsened events of macrovascular complications were shown in 21 
patients (5.3%) included 8 patients with myocardial infarction, 3 with heart failure, 1 with 
atrial fibrillation, 7 with cerebral infarction and 2 with cerebral bleeding. These new or 
worsened cumulative events were also significantly higher with sustained MH than with 
sustained MN, whereas no significant difference was seen between sustained CH and CN. 
Hypertension
(n=286) 
Hypertension
(n=283) 
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In terms of macrovascular complications, cumulative events also occurred significantly with 
sustained CH (Table 9).  
 On the outcome of each group with normotension, white coat hypertension, masked 
hypertension or sustained hypertension, we were not able to survey their outcomes with 
statistics as a cohort study, because that each number participated in this study was small. 
3.2.3 Risk factor assessment for outcomes 
In terms of death, macrovascular complications at baseline represented a significant risk 
factor for patients with sustained MH, as determined by a Cox proportional hazard model 
that was significantly (P<0.001) appropriate according to Omnibus tests. Serum creatinine 
and UAER at baseline levels also represented significant confounding factors. However, as 
hazard ratios for these parameters were 0.01 and 1.00, respectively, these represented 
negative or small associated risk (Table 10).  
In terms of microvascular complications, MH at baseline on the basis of HBP was a 
significant risk factor related to new, worsened or improved events of events according to a 
Cox proportional hazard model that was significantly (P<0.001) appropriate by Omnibus 
tests. Additional therapies for hypertension and DM also represented significantly 
confounding factors, but displayed negative associations with this outcome (Table 10).  
In terms of macrovascular complications, HbA1c and presence of micro- and macro- 
vascular complications at baseline in patients with sustained MH were significantly 
associated with this outcome, as determined by a Cox proportional hazard model that 
was significantly (P<0.001) appropriate by Omnibus tests. Additional therapy for 
hypertension represented a negative confounding factor significantly (Table 4). In 
patients with sustained CH on the basis of CBP, a Cox proportional hazard model was 
found to be significantly (P<0.001) appropriate by Omnibus tests, and additional 
therapies for hypercoagulation and others represented a significant confounding factor 
(P=0.025; Hazard ratio 5.71). No other significant risk factors were identified other than 
serum TG level at baseline (P=0.025), for which the hazard ratio was 1.00. Additional 
therapy for hypertension also represented significantly confounding factors, but 
displayed negative associations with this outcome (P=0.001; Hazard ratio 0.10) (data not 
shown in the table). 
4. Discussion 
4.1 Blood pressure (BP) 
Over the past 100 years, BP has been measured in the clinic of daytime, which has been 
called casual or clinic BP (CBP). As hypertension research and treatment methodologies 
have substantially advanced since the development of CBP, the gold standard of BP 
measurement for practice and research has been CBP (Imai et al, 2004). Namely, an 
evaluation for BP is based on the value of CBP. However, an alternative to the CBP was 
proposed soon after the introduction of BP measurements. Recent studies show that a 
discrepancy between CBP and ABPM has been noted. It has also been shown that in 
patients with essential hypertension, HBP measurement in the morning has a stronger 
predictive power for mortality than CBP measurements in the daytime (Aihara et al, 1998, 
Ohkubo et al, 1998, Imai et al, 1999). Further, BP measurements by using ABPM or HBP 
revealed that there is a white hypertension that BP by CBP in the daytime is high, whereas 
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BP byHBP in the daytime is normal or a masked hypertension that BP in the daytime is 
normal but BP in the night or in the morning is high in peoples (Pickering, 1992), whch 
has worsend outcomes for complications in patients, is paied attention to many 
researchers.     
 
 
Table 10. Risk factors for each outcome of events in patients with sustained morning 
hypertension on the basis of HBP 
macro- vascular
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4.1.1 Method for blood pressure 
4.1.1.1 Clinic Blood Pressure (CBP) 
In 1896, Riva-Rocci developed an indirect arm-cuff method for the BP measurement, and in 
1905, Korotkoff introduced the use of auscultation. Since then, the method for BP 
measurement with sphygmomanometers has remained essentially unchanged for 100 years. 
Nowadays, the oscillometric method takes the plase of sphygmomanometers for having a 
favorable environment. 
4.1.1.2 Home Blood Pressure (HBP) 
4.1.1.2.1 ABPM by automated BP measurements  
However, alternative methods to the CBP are proposed as HBP. To evaluate the HBP, many 
methods have developed in the world. One of the methods is ABPM. There are many 
reports on the results using ABPM for several decades (Imai et al, 2004). Clinically, Sokolow 
M and his colleagues developed the initial semiautomatic ABPM device in 1962. It consisted 
of a BP cuff that was manually inflated by the subject and of a tape recorder on which the 
Korotkoff sounds were recorded. Now, ABPM provides automated measurements of 
arterial BP for 24 hours or longer. Most modern ABPM monitors use the oscillometric 
technique. The monitors are programmed to take readings at desired intervals, usually 
every 15 to 30 minutes, throughout the day and night. At the end of recording, the readings 
are downloaded onto a computer.   
ABPM demonstrated the variability of BP during the daytime and its relatively poor 
correlation with CBP and first showed that ABPM correlates more closely than CBP with 
damage to heart and arteries caused by hypertension. They also provided that ABPM 
improves the ability to predict risk. Nowadays, ABPM is reliable and quiet, and can be 
programmed to be fully automatic and be worn with little discomfort. Rrecordings by 
ABPM demonstrate the well-known diurnal pattern of BP, with the higher pressures in the 
afternoon, with the lower readings in the evening, with the nadir during sleep, and the well-
reported early morning surge starting. The BP measurement by ABPM showed there is a 
white coat hypertension or a masked hypertension (Pickering, 1992). Thus, the ABPM 
provides BP information in relation to time.  
4.1.1.2.2 HBP by self-BP measurement 
Another method is self-BP measurement. In 1940, Ayman and Goldshine first reported the 
concept of "self-BP measurement" and demonstrated an apparent difference between the 
CBP and the self measured BP. Initially, self-measurement was done using the auscultation 
method. In the 1970s, an electric device based on the microphone method was marketed, but 
not widely distributed because of high price, mechanical difficulties, and the issue of 
auscultation gap. Explosive distribution of HBP measurement devices since the 1980s is 
mediated by the development of devices based on the cuffoscillometric principle. The basic 
algorithm of the principle has been improved by procedures to correctly approximate the 
characteristic changes during phase I and phase V Korotkoff sounds owing to electronic 
development. Recently, the accuracy of the automatic device is determined by comparison 
with the auscultation method and no other standard method is currently available for this 
purpose. At present, three types of electrical devices for HBP measurements are 
commercially available: the arm-cuff device, the wrist-cuff device, and the finger-cuff 
device. Ten million such electrical devices are produced each year in the Far East (including 
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Japan, Korea, Taiwan and China), which represents 85% of the world production. Of those, 
35% are wrist-cuff devices. Finger-cuff devices commanded a considerable portion of the 
market share owing to their convenience and ease-of-use. Nowdays, manufacturers have 
decreased production of finger-cuff devices owing to technical problems and extensively 
increased production of wrist-cuff devices. In Japan, wrist-cuff devices possess 30% of the 
market share. Wrist-cuff devices are much easier to handle and more portable, but include 
serious shortcomings (Imai et al., 2004). The reference level for BP measurement is the right 
atrium. When the measurement site is 10 cm below (above) the right atrium, systolic BP and 
diastolic BP are measured 7 mmHg higher (lower) than those at the level of the right atrium. 
Even after appropriate correction of the hydrostatic pressure, another issue remains 
concerning the anatomy of the wrist. At the wrist, the radial and ulnar arteries are 
surrounded by the radial bone, the ulnar bone and several long tendons, including the 
palmaris longus tendon. Therefore, even a sufficient amount of cuff pressure over the 
arterial area does not necessarily occlude these arteries completely. As a result, wrist-cuff 
devices sometime provide erroneous readings, especially for systolic BP. Therefore, arm-cuff 
devices based on the cuff-oscillometric method are recommended for HBP measurement (Imai 
et al, 2004), which is recommended by guidline of many societies for hypertension (the 
European Society of Hypertension and the European Society of Cardiology, 2007, the 
American Heart Association, American Society of Hypertension and Preventive Nurses 
Association, 2008, the Japanese Society of Hypertension , 2009). 
4.1.1.1.3 Differences between ABPM by automated-BP measurement and HBP by self-BP 
measurement 
It is very important to know the characteristcs of the difference between ABPM and HBP. 
ABPM is measured under several psychological and physiological conditions by automated 
BP measuremnt, while HBP is measured under relatively stable conditions by self-BP 
measurment. Although both ABPM and HBP are able to evaluate BP in the night-time, an 
estimation of BP in the short-time by HBP is inadequate. Meanwhile, an estimation of BP in 
the long-time for more than 24 hours including the drug effect by ABPM is inadequate and 
occasionally insufficient due to regression to the mean, and reproducibility owing to 
measure BP under psychological and physiological conditions by ABPM is poor (Imai et al, 
2004). Further, the costs for ABPM by automated BP measurement including devices are 
higher than those for HBP by self-BP measurement. However, we confirmed that ABPM is 
sometimes better to check the accuracy of HBP measurement method. 
4.1.2 Variation 
4.1.2.1 Variation of BP by HBP in healthy subjects 
There is no difference in BP by HBP using Omron device between left and right arms for a 
day and for one month. Further, there is no difference in BP using left arm- cuff by HBP 
between summer and winter.     
4.1.2.2 Variation of BP by HBP in diabetic patients 
As mentioned in above, the variation of BP by HBP at the awakening-up using wrist-cuff in 
a diabetic patient is sometimes higher than that using arm-cuff. In diabetic patients, BP by 
HBP at the wakening-up is also increased sometimes by stress for a month. In them, more 
than 10% of day-by-day coefficient variation (CV) in HBP at the wakening-up for a month 
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leads to have more occurences of complications with micro- and macro-vascular 
disturbences than less than 10% of CV (Figure 5) as shown in a diabetic patient who had 
acute myocardial infarction. These findings were demonstrated by Ohasma study (Imai et 
al, 2004). Short-term BP variability is a risk factor for cardiovascular diseases (Imai et al, 
2004). Although short-term information is available from ABPM, the information on day-by-
day variability is obtained only with home BP measurements. The Ohasama study 
demonstrated that day-by-day variability reflects the risk of cardiovascular diseases. Thus, 
home BP measurements can now replace ABPM (Imai et al , 2004).    
4.1.3 Threshold 
Subjects from the Ohasama population aged 40 years and over were followed up for an 
average of 10.6 years. In the study, when the relationship between BP level and stroke 
incidence being analyzed by a Cox regression model was adjusted for age, sex, and drug 
treatment, the study suggested that there is higher predictability of HBP when compared 
with CBP. The linear regression analysis deduced that 140/90 mmHg for CBP corresponds 
to 125/80 mmHg for HBP, suggesting that the normative value of HBP is less than 125/80 
mmHg (Imai et al, 2004) 
 
In our study, we used thresholds of once HBP value at the awakening-up in the morning 
and those of CBP in the daytime as <130/85 mmHg value based on the criteria of CH owing 
to the 1999 WHO-International Society of Hypertension guidelines (Guide lines 
Subcommittee, 1999). This studies showed the threshold of 130 mmHg of systolic BP at the 
awakening-up in the morning for micro- and macro-vasclualr complications is significant 
(Figure 3), while diastolic BP of HBP at the wakening-up is persistently referred to assement 
the BP for the complications.  
 
 
Fig. 5. Relationship between variations of BP by HBP measured at the awakening-up in the 
morning and vascular comlications in diabetic patients in comparison with those of less than 
10% and more than 10% of CV for a month. In diabetic patients, the mean of more than of 
10% for CV has demonstrated that there were more complications than that of less than 10% 
for CV.   
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Recently, all guidelines recommended a threshold for HBP by 5-10 mmHg is lower than for 
CBP (Mancia et al, 2007, Pickering et al, 2008, Ogihara et al, 2009). The guidelines indicated 
that the target HBP goal for treatment is <130–135/85 mmHg in the morning (Mancia et al, 
2007) and <135/85 mmHg or <130/80 mmHg in the morning in high-risk patients 
(Pickering et al, 2008). The Japanese Society of Hypertension defined the threshold of 
controlled BP is < 135 /85 mmHg of HBP in the morning (Ogihara et al,2009). 
 
 
Fig. 6. Event-free survival curve of primary endpoints in patients with type 2 diabetes in a 
longitudinal study. Normo; MN and CN, mHT; MH, oHT; CH, HT; MH and CH 
 
 
Fig. 7. Event-free survival curve of secondary endpoints in patients with type 2 diabetes in a 
longitudinal study. Normo; MN and CN, mHT; MH, oHT; CH, HT; MH and CH 
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4.2 In a cross-sectional study 
4.2.1 In a type 1 diabetes mellitus  
As shown in the figure 1, in the type 1 diabetic groups with CH or CN, the anti-hypertensive 
medicines in the groups with MH were larger number than in the groups with MN. The 
prevalence of nephropathy in the patients with MH was significantly higher than in those 
without MH, even though they had CN (Table 2). In contrast, the occurrence was not 
observed in those without MH, even though they had CH. Specifically, nephropathy, 
including clinical albuminuria, was observed in patients with systolic MH but not in 
patients without MH. Analysis by ROC curves also indicates that home BP in the morning 
has a stronger predictive power than clinic BP, especially in nephropathy (Figure 2). The cut 
point of 130-mmHg morning systolic BP has higher sensitivity and higher specificity than 
that of clinic systolic BP (Figure 3). This finding indicates that nephropathy in type 1 diabetic 
patients may be strongly related to morning home BP rather than clinic BP (Kamoi et al, 
2003). The reason may be explained by several factors, such as white coat hypertension, 
nondipper hypertension, and morning surge. Particularly, an increase in nocturnal BP, as 
detected by ABPM, in type 1 diabetes is related to the development of microalbuminuria 
(Moore et al, 1992, Lurbe et al, 2003). These phenomena are thought to be caused by many 
neuroendocrine and hematological factors, especially autonomic neuropathy (Spallone et al, 
1993, Lafferty et al, 2000, Torbjornsdotter et al, 2001). Although we did not measure 24-h 
ambulatory BP, the greater range in the relation of morning home BP and clinic BP may be 
partially explained by true and white coat hypertension, reverse-dipping hypertension, and 
the effects of treatment with anti- hypertensive drugs.  In contrast, the prevalence of 
retinopathy in type 1 diabetic patients did not relate to BP, including morning home BP, 
although the degree of retinopathy was strengthened by MH. The duration of diabetes 
contributed to retinopathy significantly. They support the hypothesis that sustained long-
term hyperglycaemia is the strongest predictor for developing retinopathy and that high 
morning home BP accelerates retinopathy as well as nephropathy.                                             
4.2.2 In a type 2 diabetes mellitus  
In the type 2 diabetic patients who were regularly treated with diet and exercise or 
medications for hyperglycaemia and hypertension, we found that one half of CH patients 
had MN, whereas two thirds of CN patients had MH. The prevalences of nephropathy, 
retinopathy, CHD, and CVD in patients with MH were significantly higher than in patients 
without MH, even though they had CN. In contrast, the prevalence of these vascular 
disturbances was significantly lower in patients without MH than in patients with MH, even 
though they had CH. Specifically, nephropathy, including clinical albuminuria, was 
observed in patients with systolic MH but not in any patients without MH. The difference is 
not related to age, sex, BMI, HbA1c, serum lipid concentrations, or use of anti-diabetic and 
anti-hypertensive drugs. The finding in the present cross-sectional study indicates that 
micro- and macro- vascular complications of type 2 diabetic patients may be strongly related 
to HBP in the morning rather than CBP.  
The reason for the underlying relation of high HBP in the morning rather than high CBP to 
the vascular complications is not clearly determined by this study. However, several 
possibilities are postulated. First, type 2 diabetic patients have high prevalence of increased 
CBP but normal HBP in the morning (white coat hypertension) (Burgess et al, 1991, Puig et 
al, 1995). White coat hypertension seems to be a low risk for vascular complications 
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(Pickering, 1996, Nielson et al, 1997). Second, O’Brien et al (O’Brien et al, 1988) and Imai et al 
(Imai et al, 1990) reported that nocturnal decline in BP in patients with essential 
hypertension is often diminished (non-dipper hypertension) and sometimes inverts to 
become a nocturnal elevation (inverted dipper hypertension). Non-dipper hypertension, 
particularly inverted dipper hypertension, accelerates vascular disturbances (Shimada et al, 
1990, Okubo et al, 1997), including microalbuminuria (Opsahl et al, 1988). Many studies 
have reported that type 2 diabetic patients have non-dipper hypertension (Forgari et al, 
1994, Spalone et al, 1993, Farmer et al, 1998, Sturrock et al, 2000, White, 2001, Aronson, 2001). 
Therefore, it seems that blunted nocturnal and/or inverted dipper hypertension may cause 
micro- and macro- vascular complications in type 2 diabetic patients. Third, a morning 
surge in BP may be related to these events. A number of reports indicate that the early 
morning surge in BP acts as a trigger for vascular events (White, 2001, Aronson, 2001). Most 
diabetic patients have the morning surge (Aronson, 2001). These phenomena in diabetic 
patients are considered to be caused by many neuroendocrine and haematological factors, 
including autonomic neuropathy, which may result in glomerular hyperfiltration, 
hypercoagulability, and hypofibrinolysis, promoting micro- and macro- vascular 
disturbances. In fact, a high prevalence of these phenomena was observed in MH but not in 
MN. In addition, the severity of MH in CN patients tended to be greater than in CH 
patients. Moreover, the relation of MBP and CBP levels was a greater range, indicating true 
and white coat hypertension, and MBP level in some patients was higher than the 
corresponding CBP level, indicating that reverse dipping hypertension might occur, 
although we did not measure 24-h ambulatory BP. It is hypothesized that treatment with 
anti- hypertensive drugs reduced daytime BP but did not restore blunted nocturnal 
hypertension, did not decrease nocturnal hypertension, and could not attenuate the 
morning surge in BP (Spalone et al, 1993, Imai et al, 1999). The greater range in relation of 
MBP and CBP, and the negative association between events of nephropathy and clinic DBP 
may be partially explained by the effect of treatment with anti- hypertensive drugs, as 
hypothesized above.  
Analysis by ROC curves also indicates that HBP has a stronger predictive power than CBP, 
especially in nephropathy. The cut points of 130/85 mmHg have higher sensitivity in 
morning measurement than in clinic measurement (Figure 2), although specificity in the cut 
point of 130 mmHg SBP in the morning measurement was lower than in the clinic 
measurement. Accordingly, measurement of HBP in the morning is a useful method of 
determining these phenomena, as indicated by the Ohasama study (Imai et al, 1990-2004, 
Okubo et al, 1995-1998), and high HBP levels at the awakening-up in the morning in type 2 
diabetic patients may be related to micro- and macro- vascular complications of diabetes.  
All findings indicate that high BP levels at the awakening-up in the morning, obtained by 
means of self-measurement in type 2 diabetic patients, should be treated as hypertension.  
4.3 In a longitudinal study  
4.3.1 General 
We analysed the influence of HBP at the awakening-up in the morning and of CBP in the 
daytime on outcomes of events including death, microvascular complications as 
nephropathy and retinopathy, and macrovascular complications as CHD and CVD for data 
obtained over 6 years in a prospective, longitudinal study of type 2 diabetic patients. To 
clarify which of HBP or CBP provides the stronger predictive power for the outcomes, the 
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400 patients were classified as with or without hypertension based on HBP and CBP 
measurements at baseline, because that although the cross-sectional studies have 
demonstrated that HBP measurements at the awakening-up in the morning offer stronger 
predictive power for micro- and macro-vascular complications in patients with type 1 and 2 
DM than CBP measurements in the daytime (Kamoi et al, 2002-2003) and the MH may be 
caused by micro- and macro-vascular complications.   
All subjects were Japanese patients with type 2 diabetes. Subject characteristics were broadly 
similar to those described previously (Kamoi et al, 2002), except that patients with CH 
showed a higher prevalence of nephropathy than patients with CN. 
Recently, all guidelines recommended a threshold for HBP by 5-10 mmHg lower than for 
CBP (Mancia et al, 2007, Pickering et al, 2008, Ogihara et al, 2009) as mention. In this study, 
the use of the same thresholds based on the criteria of CH owing to the 1999 WHO-
International Society of Hypertension guidelines (WHO, 1999) for both methods resulted to 
MN patients with higher threshold and more severe MH patients selected with HBP. 
Nevertheless, the cumulative event of death was observed in sustained MH patients, but not 
in sustained MN patients. United Kingdom Prospective Diabetes Study (UKPDS) reported 
that the cumulative incidence of death was 12.4 % (597 of 4801 patients with type 2 diabetes) 
for ten years (Adler et al, 2000). In the study, the incidence was 2.3 % for 6 years. Although 
the reason is unclear why the incidence in this study is lower than in UKPDS, the hazard 
ratio was significantly (5-fold) higher in sustained MH patients than in sustained MN 
patients, while no significant difference was seen between sustained CH and CN patients. In 
addition, cumulative events of new or worsened microvascular complications were 
significantly (2-fold) higher in sustained MH patients than in sustained MN patients, while 
no significant difference was seen between sustained CH and CN patients. The incidence of 
the events is about 50% higher in the MH patients as compared to the MN patients (19.2% 
vs. 14.9%), while the hazard ratio indicates that the risk of an event in the MH patients is 
about twice as high as the risk of an event in the MN patients. This may be explained by that 
the follow-up time in the MH patients is much shorter than the follow-up time in the MN 
patients. Furthermore, UKPDS reported that the cumulative incidence of CHD was 12.5 % 
(600 of 4801 patients with type 2 diabetes) for ten years. In the study, the incidence was 5.3 
% for 6 years. Also, although the reason is unclear why the incidence in this study is lower 
than in UKPDS (Adler et al, 2000), cumulative events of new or worsened macrovascular 
complications were significantly higher in sustained MH patients than in sustained MN 
patients, and significantly higher in sustained CH patients than in sustained CN patients.  
The present results indicate that cumulative events of death and new or worsened micro-
and macro- vascular complications are more strongly related to sustain MH, although 
sustained CH is also related to them,  
In terms of death among sustained MH patients, the finding that presence of macrovascular 
complications at baseline was a significant risk factor indicates that sustained MH may be a 
trigger for death among patients with macrovascular complications. In the event of new or 
worsened microvascular complications, the fact that MH at baseline was the only associated 
risk factor indicates that sustained MH also represents a strong contributor to new or 
worsened microvascular complications. The finding that additional therapy for 
hypertension suppressed occurrence of new or worsened microvascular complications 
supports this view. In the event of new or worsened macrovascular complications, the 
identification of glycaemic control and presence of micro- and macro- vascular 
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complications at baseline among patients with sustained MH as associated risk factors 
indicates that sustained MH, as along with glycaemic control and presence of micro- and 
macro-vascular complications (American Diabetes Association, 2009), is important risk 
factor. It is supported this view that age, sex, serum creatinine, LDL and proteinuria were 
not risk factors. Moreover, additional therapy for hypertension improved or prevented the 
macrovascular events, supporting this idea. Meanwhile, the finding that sustained CH was 
related to the macrovascular events is consistent with the findings of a previous report 
(Aldler et al, 2000). Accordingly, not only sustained CH but also sustained MH is related to 
the new or worsened macrovascular events.   
All findings indicated that events of death and new or worsened micro- and macro-vascular 
complications in type 2 diabetic patients are strongly related to sustained MH, irrespective 
of sustained CH as demonstrated in a cross-sectional study (Kamoi et al, 2002-2003) and in 
the Ohasama study (Okubo et al, 1998), and support the view that the available evidence 
suggests that HBP has strong prognostic value, which appears to be superior to that of the 
conventional CBP measurements. The reasons of differencnt results by studies of ACCORD 
and Cooper-DeHoff et al may be obtained by evaluation of BP by HBP measurement at the 
wakening-up. 
4.3.2 Limitations of this study 
In a longitudinal study, this study was that the numbers of patients participating and 
events occurring over the 6 years of the study were heterogeneous and small, so we were 
unable to survey outcomes and compare differences among baseline groups of patients 
with MH, MN, CH and CN as a cohort study. Further, there were no evening 
measurements as well as 24 hours BP monitoring to compare them. Instead, we classified 
the 400 patients into patients with or without hypertension based on HBP and CBP 
measurements and compared differences in cumulative events between sustained 
hypertensive and normotensive patients in each group. These patients’ classifications 
obviously overlapped. Accordingly, the censoring date depends on whether HT and NT 
are defined according to CBP or HBP and the same censoring time was not used in the 2 
analyses. Furthermore, for ethical reasons, most patients received treatment with various 
anti-hypertensive agents and other medications during follow-up. Therefore, we were 
unable to examine outcomes without changing treatments from baseline over the 6 years 
of the study and whether these drugs would thus have influenced the outcomes of events 
in this study. At baseline 49% of the subjects received anti- hypertensive treatment. Anti- 
hypertensive drugs are most likely prescribed on the basis of CBP. Therefore, somebody 
argues that it is not appropriate to classify patients taking anti- hypertensive drugs and 
having a normal BP as normotension, and the untreated CBP in most of these patients 
may be probably in the hypertensive range. This may introduce a bias in the comparison 
between CBP and HBP. 
Particularly, it is clinically more informative to evaluate the prognostic value of both white 
coat hypertension and masked hypertension based on CBP and HBP among subjects with 
diabetes. However, we were not able to survey their outcomes with statistics as a cohort 
study, because that each number participated in this study was small. 
Someone may indicate that the prognostic values of CBP and HBP should be assessed as not 
only categorical data, but also continuous variables. The analysis using continuous variables 
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may give more significant meaning, but in this study, BP as continuous variables showed 
high fluctuation and the numbers participated were small. Accordingly, as the analysis with 
statistics is complex, we did not examine it in this study.  
By meta-analysis, compared with clinic BP monitoring alone, systolic BP at daytime by 
home BP monitoring has the potential to overcome therapeutic inertia and lead to a small 
but significant reduction in systolic and diastolic BP. Hypertension control with home BP 
monitoring can be enhanced further when accompanied by plans to monitor and treat 
elevated BP, although there is not a systematic review on the morning BP by home BP 
measurement (Agarwal et al, 2011). 
4.3.3 A mechanism undering awakening-up hypertension related to vascular 
complications in patients with diabetes mellitus 
As shown in Figure 8, when subjects had awakening-up from sleeping, their parasympathic 
activity changed to sympathic activity. Such changes at the awakening-up have most 
increase in activiation of renin-angiotenin-aldosteron-vasopressin system, coaglulation 
system and oxidant stress, and most decreases in activation of plasminogen activator 
inhibitor and fibilinolytic system. The alterations have companied with most conctriction of 
blood vessel owing to most decreased endothelial function in the day (Figure 9) (Otto et al, 
2004). In the states, hypertension may lead to have a vascular injury, resulting in vascular 
disturbances. Most patients with diabetes have hypertension when we used measurement of 
BP by HBP at the awkening-up as well as CBP in the daytime.   
 
ＳleepingsAwakening
(Clock BMAL 1 gene in SCN ?)
Renin-Angiotensin-
Aldosterone-Vasopressinr PAIr FLSt CGSr Oxidant Stressr(ROS)
Micro- and macro-vascluar disturbances
Hypertension
Parasympathetic activity⇒Sympathetic activity
Endothelial function t
 
Fig. 8. Scheme of mechanism underling awakening-up hypertension related vascular 
disturbences in diabetic patients. BMAL ; Brain-Muscle-Arnt-Like-protein, SCN ; supra optic 
nucleus, PAI; plasminogen activator inhibitor, FLS ; fibilinolytic system, CGS; coaglulation 
system 
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Fig. 9. Change in diameter of brachial artery at the awakening-up, after the wakening and 
before sleeping in the supine postion of healthy subjects by evaluation using flow-mediated 
echogram.   
4.3.4 A reason why we measure BP at the wakening-up by HBP 
There were more occurrences of CVD and CHD in the morning and in the evening in 
Japanese peoples in 1994 (Sato et al, 1994). However, the reason was unclear. Also, Stergiou 
GS et al in 2002 showed that the incidences of vascular complications in patients with 
hypertension at the awakening-up in Siesta were greater number than those in patients with 
normotension at the awakening-up (Stergious et al, 2002) (Figure 10). Our previous studies 
demonstrated that secretions of hormones related to BP in the upright position are higher 
than in the recumbent position (Kamoi et al, 1988). These findings indicated that the 
differences may be related to the difference of parasymapthic- and sympathic-nerves 
activities. Further, the increased hormones have decresded immediately after bias by 
various factors including own or other helps. In fact, HBP at the morning has been 
decreased immediately after awakening-up and second or third measurement of HBP is 
more decreased than first measurement of BP. Therefore, we chosed first HBP measurement 
once at the awakening-up except another points of BP in a day, although someone thinks 
that the once mesurment may be strict, because that many reseachers have a mean of BP for 
several mesuremnts of BP becasuse that most patients desire to pass urine after awakening. 
When they are unbearable to pass it, I recommend once measurement of BP after passing the 
urine. Most patients have awakening-up in the eary morning, but some patients who have 
worked in midnight have awakening-up in the late morning. Therefore, I recommend 
patients to measure BP at awakening-up in the day. The method is simple and accurate to 
assess HBP. 
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Fig. 10. Relationship between systolic blood pressure at the awkening-up in Siesta of Greece 
and cerebral vascular diseases (CVD). 
4.3.5 An usefulness of BP by HBP in the disaster 
First, Kario et al observed that there were more occurences CVD or CHD in patients with 
MH, which increased after several days after Hanshin-Awaji earthquake using ABPM in 
1994 (Kario et al, 2002). The mechanism may be due to activity of sympathic nerve, which 
was supported by administration of α blockers. They proposed if peoples have the MH by 
HBP or ABPM, α blockers administration into the peoples have been recommended, which 
needs few weeks post the disaster. To evaluate MH in the morning, BP must be measured 
by a device of measurements HBP or ABPM. However, in Japan, nowadays, peoples in the 
public refuge houses have BP measurement in the daytime, but not upon awakening in the 
morning.  
Our experices in the 2004 Mid-Niigata Prefecture Earthquake in 2004 (Kamoi et al, 2006) 
are same as Kario et al. The patients measured HBP in the awkening-up in his own house 
showed an increased HBP within a few weeks afer earthquake and the patients 
suppressed HBP in the awalening-up by taking anti-hypertensive medicines for MH 
before the earthquake had no vascular complications (Figure 12), whereas peoples 
without measured HBP had many CHD, CVD or dialysis during 6 months after the 
earthquake (Kamoi et al, 2006). These findings suggest that it is important to control MH 
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as we11 as CH during a disaster to prevent vascular complications, particularly such as 
nephrophaty. However, our study showed only one-third of patients measured their HBP 
within three months after the shock. Although the reasons why they did not measure their 
HBP were not clarified by the study, it is known that some patients lost their HBP 
measurement equipment, some had their equipment destroyed, and some suffered from 
anxiety, in particular sleep disturbance, as result of the devastation caused by the strong 
earthquake. In the public refuge houses, all patients have BP measurements in the 
daytime as the report by Kario et al, but not upon awakening in the morning. Therefore, 
we recommend strongly that there is need to develop a procedure of BP measurement 
upon awakening in the morning during a disaster in the public refuge houses as well as in 
their homes and to educate individuals about appropriate adaptation mechanisms 
following a disaster such as taking special care of themselves during the initial three 
months following a disaster. Appropriate information about morning hypertension 
should be provided to all affected people using all possible means, including the mass 
media, to decrease the potential for adverse consequences. 
4.3.6 Treatment methods for awakening-up hypertension, by HBP in patients with 
diabetes melitus 
First, restriction of salt ingestion in diabetic patients is necessary to have better BP by HBP at 
the awakening-up as patients with hypertension in the daytime. As hyperglycaemia causes 
increased urinary excretion of glucose via convoluted tubule, reabsorption of sodium cloride 
from the convoluted tubule into blood is increased. Hence, volume expansion in the blood 
and activation of sympathic nerve occure in them. They lead to occure MH in the morning 
as CH in the daytime. Therefore, restriction of salt ingestion (less than 7.0 g/day) is usefull 
to control MH.  
Second, howeve, the treatment is not effective in most diabetic patients. Some patients 
have MN in the admission of hospital, but have MH in their homes. Probably, the 
sympathic activity of them may increase in the daily life, which shows the MH at the 
awakening-up but CN in the daytime as masked hypertension. Further, some patients 
have orthostatic hypotension by nerve disturbenes, which shows that BP are hypotension 
by CBP in the daytime, whereas they are MH by HBP at the awakening-up in the 
morning. In such patients, switched bedtime adminstration of α blockers is effective 
(Figure 11) (Kamoi et al, 2006).  
Third, when the patients have CH in the daytime and MH at the awakening-up, 
administration of long active anti-hypertensive medicines after taking breakfast as a 
conventinal method for hypertension is usfull. Sometimes, such adminstraton is not 
effective in the patients with MH. In that case, switched bedtime administration is effective 
(Kamoi et al, 2006). In the world, many studies by researchers on administration methods of 
them are proceeding.  
Fourth, we meet many patients who had albeit such treatments, the therapy had no effective 
for MH. In such diabetic patients, clock time disturbed may be accompanied (Figure 8). As it 
is difficult to treat such patients, the treatment methods remain to be not resolved 
completely. 
Any way, controlling high BP at the wakening-up by using various methods prevents for 
micro- and macro- vascluar complications. 
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Fig. 11. Effect ofαblocker administration at bedtime in type 2 diabetic patients on 
nephropathy. The patients were treated with doxosine received at bedtime for 3 years for 
MH. 
 
 
Fig. 12. Effect of earthquake (magnitude 7.0) on HBP and CBP at the awakening-up in type 2 
diabetic patients for 6 months. Increased BP at the awakening-up in the morning owing to 
devastation by earthquake continued for several months, whereas CBP was not changed, 
eventhough the patient had received anti-hypertensive medicines before occuring 
earthquake. 
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5. Conclusion 
In conclusion, elevations of blood pressure on self-measurement at the awakening-up in the 
morning as well as clinical blood pressure measurement in the daytime in type 1 and 2 
diabetic patients are strongly related to microvascular complications, especially 
nephropathy, and the control of morning hypertension may prevent to have a development 
of micro- and macro-vascular complications in patients with diabetes mellitus.   
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